|
|
Volumn 21, Issue 5, 1999, Pages 917-930
|
|
Letter to the editor [2] (multiple letters)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
OLANZAPINE;
RISPERIDONE;
BENZODIAZEPINE DERIVATIVE;
DRUG DERIVATIVE;
PIRENZEPINE;
CLINICAL RESEARCH;
COST EFFECTIVENESS ANALYSIS;
DATA ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG MARKETING;
DRUG RESEARCH;
DRUG UTILIZATION;
LETTER;
AUSTRALIA;
HOSPITALIZATION;
HUMAN;
METHODOLOGY;
NOTE;
REPRODUCIBILITY;
TREATMENT OUTCOME;
AUSTRALIA;
BENZODIAZEPINES;
DRUG UTILIZATION;
HOSPITALIZATION;
HUMANS;
PIRENZEPINE;
REPRODUCIBILITY OF RESULTS;
RESEARCH DESIGN;
RISPERIDONE;
TREATMENT OUTCOME;
|
|
EID: 0033126595
PISSN: 01492918
EISSN: 1879114X
Source Type: Journal
DOI: 10.1016/S0149-2918(99)80063-0 Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|
